国产精品久久久久久一级毛片,国产愉拍91九色国产愉拍,www.71.com色婬免费,分类 - 91Porn,无码人妻丰满熟妇bbbb,午夜成人免费视频,中文字幕一区二区无码成人,四川BBBB搡BBB搡B1 ,国产黄色在线观看,无码人妻AⅤ一区二区三区玉蒲团,好吊视频一区二区三区四区,国内精品人妻无码久久久影院蜜桃 ,精品人妻一区二区三区日产乱码,无码国产精品一区二区三,亚洲精品视频在线播放,久久久久久久久久成人无码

中文
中文
為了病患而驅(qū)動(dòng)的創(chuàng)新
Patient-first cell therapy innovation
 

Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy
  • 0


On the cover: 
The transdifferentiation paths of erythroid precursor cells (EPCs) under the influence of tumor is delineated from Palantir algorithm‐based single-cell transcriptomic trajectory analysis (Long et al., 674–693), and embedded into artwork inspired by Wassily Kandinsky's “Composition 8.” As acquired “organs,” tumors exert a self-beneficial influence on the immune system by hijacking of erythropoiesis for myelopoiesis. Besides exacerbating anemia, CD45+ EPCs transdifferentiation generates myeloid cells that robustly curtail anti‐tumor immunity. Clinically, the abundance of these converted cells predicts immune tolerance in many human tumor types and resistance to immune checkpoint inhibitor treatment. Design and painting by Yijie Hou. Conceptual visualization by Qi-Jing Li and Bo Zhu.

https://www.cell.com/cancer-cell/current#closeFullCover

 

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網(wǎng)安備 44011502000528號(hào)

粵ICP備20056630號(hào) Powered by vancheer
關(guān)于天科雅
研究與發(fā)展
產(chǎn)品及臨床
新聞與媒體
招賢納士

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網(wǎng)安備 44011502000528號(hào)

粵ICP備20056630號(hào) Powered by vancheer
饶阳县| 阳新县| 南乐县| 广河县| 沈阳市| 天津市| 米泉市| 渭南市| 柳州市| 沛县| 寻乌县| 澄迈县| 郓城县| 延津县| 和龙市| 汉寿县| 石门县| 红安县| 长宁县| 广饶县| 龙胜| 望都县| 桐乡市| 田东县| 灵丘县| 易门县| 伊吾县| 巴楚县| 鲜城| 新巴尔虎左旗| 太仓市| 武安市| 屯留县| 陆丰市| 宁德市| 天水市| 繁峙县| 万全县| 永福县| 卢龙县| 吴川市|